Certified by Founder Lodge
Asher Biotherapeutics
United States - South San Francisco , California
START UP
1 Disclosed Funding Rounds $55,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Asher Bio is a biotechnology company developing precisely targeted immunotherapies for cancer and other diseases. Our cis-targeting platform aims to enable selective activation of specific im
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| April, 17 ,2024 | Series C | $55,000,000 |
Wellington Management
RA Capital Management, L.P.
Janus Henderson Investors
Third Rock Ventures
Bristol Myers Squibb
Boxer Capital, LLC
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)